# Post-Approval Safety Monitoring Program to Assess the Safety Profile of GARDASIL in China Usual Practice

> **NCT03659110** · — · UNKNOWN · sponsor: **Beijing Chaoyang District Centre for Disease Control and Prevention** · enrollment: 1000 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **BIOLOGICAL:** HPV 4

## Key facts

- **NCT ID:** NCT03659110
- **Lead sponsor:** Beijing Chaoyang District Centre for Disease Control and Prevention
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-01
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2018-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03659110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03659110, "Post-Approval Safety Monitoring Program to Assess the Safety Profile of GARDASIL in China Usual Practice". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03659110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*